SC 13G Filing

Company

Insight Molecular Diagnostics Inc.

Filed

October 9, 2024

Accession Number

0001493152-24-040618

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →